T1	tradename 0 8	ABRAXANE
T3	activeingredient 37 47	paclitaxel
T5	tradename 170 178	ABRAXANE
T7	tradename 242 262	ABRAXANE.  ABRAXANE
T9	nanoparticle 291 325	paclitaxel protein-bound particles
T11	corecomposition 354 367	albumin-bound
T13	fdaapprovaldate 393 397	2005
T15	tradename 501 509	ABRAXANE
T17	activeingredient 786 796	PACLITAXEL
T19	tradename 1074 1082	ABRAXANE
T21	chemoclass 1088 1109	microtubule inhibitor
T23	indication 1142 1166	Metastatic breast cancer
T25	indication 1402 1447	metastatic non-small cell lung cancer (NSCLC)
T27	indication 1591 1632	Metastatic adenocarcinoma of the pancreas
T29	indication 1773 1798	Metastatic Breast Cancer:
T31	tradename 1821 1829	ABRAXANE
T33	dose 1833 1842	260 mg/m2
T35	routeofadministration 1843 1856	intravenously
T37	indication 1895 1922	Non-Small Cell Lung Cancer:
T39	tradename 1945 1953	ABRAXANE
T41	dose 1957 1966	100 mg/m2
T43	routeofadministration 1967 1980	intravenously
T45	tradename 2111 2120	ABRAXANE.
T47	indication 2128 2159	Adenocarcinoma of the Pancreas:
T49	tradename 2182 2190	ABRAXANE
T51	dose 2194 2203	125 mg/m2
T53	routeofadministration 2204 2217	intravenously
T55	tradename 2361 2370	ABRAXANE.
T57	tradename 2396 2404	ABRAXANE
T59	tradename 2488 2496	ABRAXANE
T61	indication 2514 2555	metastatic adenocarcinoma of the pancreas
T63	indication 2629 2670	metastatic adenocarcinoma of the pancreas
T65	activeingredient 3230 3240	paclitaxel
T67	corecomposition 3255 3268	albumin-bound
T69	tradename 3498 3507	ABRAXANE.
T71	tradename 3589 3597	ABRAXANE
T73	tradename 3872 3880	ABRAXANE
T75	tradename 3924 3932	ABRAXANE
T77	tradename 4129 4137	ABRAXANE
T79	tradename 4210 4218	ABRAXANE
T81	activeingredient 4385 4395	paclitaxel
T83	tradename 4492 4500	ABRAXANE
T85	tradename 4745 4754	ABRAXANE.
T87	tradename 4810 4819	ABRAXANE.
T89	indication 4959 4983	metastatic breast cancer
T91	adversereaction 4988 4996	alopecia
T93	adversereaction 4998 5009	neutropenia
T95	adversereaction 5011 5029	sensory neuropathy
T97	adversereaction 5031 5043	abnormal ECG
T99	adversereaction 5045 5061	fatigue/asthenia
T101	adversereaction 5063 5081	myalgia/arthralgia
T103	adversereaction 5083 5096	AST elevation
T105	adversereaction 5098 5128	alkaline phosphatase elevation
T107	adversereaction 5130 5136	anemia
T109	adversereaction 5138 5144	nausea
T111	adversereaction 5146 5156	infections
T113	adversereaction 5162 5171	diarrhea.
T115	indication 5231 5236	NSCLC
T117	adversereaction 5241 5247	anemia
T119	adversereaction 5249 5260	neutropenia
T121	adversereaction 5262 5278	thrombocytopenia
T123	adversereaction 5280 5288	alopecia
T125	adversereaction 5290 5311	peripheral neuropathy
T127	adversereaction 5313 5319	nausea
T129	adversereaction 5325 5333	fatigue.
T131	tradename 5393 5401	ABRAXANE
T133	indication 5405 5435	adenocarcinoma of the pancreas
T135	adversereaction 5440 5451	neutropenia
T137	adversereaction 5453 5460	fatigue
T139	adversereaction 5462 5483	peripheral neuropathy
T141	adversereaction 5485 5491	nausea
T143	adversereaction 5493 5501	alopecia
T145	adversereaction 5503 5519	peripheral edema
T147	adversereaction 5521 5529	diarrhea
T149	adversereaction 5531 5538	pyrexia
T151	adversereaction 5540 5548	vomiting
T153	adversereaction 5550 5568	decreased appetite
T155	adversereaction 5570 5574	rash
T157	adversereaction 5580 5592	dehydration.
T159	company 5647 5666	Celgene Corporation
T161	tradename 5864 5872	ABRAXANE
T163	indication 6128 6152	Metastatic Breast Cancer
T165	indication 6159 6185	Non-Small Cell Lung Cancer
T167	indication 6192 6222	Adenocarcinoma of the Pancreas
T169	indication 6260 6284	Metastatic Breast Cancer
T171	indication 6292 6318	Non-Small Cell Lung Cancer
T173	indication 6325 6355	Adenocarcinoma of the Pancreas
T175	routeofadministration 6531 6542	Intravenous
T177	corecomposition 6787 6794	Albumin
T179	indication 6904 6928	Metastatic Breast Cancer
T181	indication 6966 6992	Non-Small Cell Lung Cancer
T183	indication 7029 7059	Adenocarcinoma of the Pancreas
T185	tradename 7098 7106	ABRAXANE
T187	activeingredient 7117 7127	Paclitaxel
T189	indication 7601 7625	Metastatic Breast Cancer
T191	indication 7634 7660	Non-Small Cell Lung Cancer
T193	indication 7669 7699	Adenocarcinoma of the Pancreas
T195	tradename 8002 8010	ABRAXANE
T197	nanoparticle 8039 8073	paclitaxel protein-bound particles
T199	corecomposition 8102 8115	albumin-bound
T201	tradename 8158 8166	ABRAXANE
T203	tradename 8485 8493	ABRAXANE
T205	corecomposition 8604 8611	albumin
T207	activeingredient 8620 8630	paclitaxel
T209	activeingredient 8762 8772	PACLITAXEL
T211	indication 8819 8843	Metastatic Breast Cancer
T213	tradename 8844 8852	ABRAXANE
T215	indication 9113 9139	Non-Small Cell Lung Cancer
T217	tradename 9140 9148	ABRAXANE
T219	indication 9214 9251	metastatic non-small cell lung cancer
T221	indication 9369 9399	Adenocarcinoma of the Pancreas
T223	tradename 9400 9408	ABRAXANE
T225	indication 9468 9509	metastatic adenocarcinoma of the pancreas
T227	indication 9580 9604	Metastatic Breast Cancer
T229	indication 9651 9675	metastatic breast cancer
T231	tradename 9757 9765	ABRAXANE
T233	dose 9769 9778	260 mg/m2
T235	routeofadministration 9792 9805	intravenously
T237	frequency 9822 9836	every 3 weeks.
T239	indication 9843 9869	Non-Small Cell Lung Cancer
T241	tradename 9894 9902	ABRAXANE
T243	dose 9906 9915	100 mg/m2
T245	routeofadministration 9935 9946	intravenous
T247	tradename 10088 10096	ABRAXANE
T249	indication 10134 10164	Adenocarcinoma of the Pancreas
T251	tradename 10189 10197	ABRAXANE
T253	dose 10201 10210	125 mg/m2
T255	routeofadministration 10230 10241	intravenous
T257	tradename 10355 10363	ABRAXANE
T259	tradename 10748 10756	ABRAXANE
T261	indication 10774 10815	metastatic adenocarcinoma of the pancreas
T263	tradename 10883 10891	ABRAXANE
T265	tradename 11281 11289	ABRAXANE
T267	indication 11298 11307	MBC NSCLC
T269	indication 11683 11686	MBC
T271	indication 11689 11713	Metastatic Breast Cancer
T273	indication 11715 11720	NSCLC
T275	indication 11723 11750	Non-Small Cell Lung Cancer.
T277	dose 11942 11951	260 mg/m2
T279	indication 11970 11994	metastatic breast cancer
T281	dose 11998 12007	100 mg/m2
T283	indication 12026 12052	non-small cell lung cancer
T285	indication 12342 12366	Metastatic Breast Cancer
T287	adversereaction 12391 12409	severe neutropenia
T289	tradename 12505 12513	ABRAXANE
T291	dose 12552 12561	220 mg/m2
T293	tradename 12588 12600	ABRAXANE. 
T295	adversereaction 12618 12636	severe neutropenia
T297	adversereaction 12640 12665	severe sensory neuropathy
T299	dose 12711 12720	180 mg/m2
T301	adversereaction 12728 12754	Grade 3 sensory neuropathy
T303	tradename 12863 12871	ABRAXANE
T305	tradename 12967 12968	 
T307	indication 12968 12994	Non-Small Cell Lung Cancer
T309	tradename 13014 13022	ABRAXANE
T311	tradename 13654 13662	ABRAXANE
T313	tradename 13719 13727	ABRAXANE
T315	adversereaction 13732 13764	Grade 3-4 peripheral neuropathy.
T317	tradename 13774 13782	ABRAXANE
T319	adversereaction 13835 13856	peripheral neuropathy
T321	indication 14060 14065	NSCLC
T323	tradename 14109 14117	ABRAXANE
T325	tradename 14641 14644	 
T327	indication 14644 14674	Adenocarcinoma of the Pancreas
T329	indication 14715 14745	adenocarcinoma of the pancreas
T331	indication 14855 14885	Adenocarcinoma of the Pancreas
T333	tradename 14899 14907	ABRAXANE
T335	indication 15161 15191	adenocarcinoma of the pancreas
T337	indication 15366 15396	Adenocarcinoma of the Pancreas
T339	tradename 15453 15461	ABRAXANE
T341	indication 16161 16191	adenocarcinoma of the pancreas
T343	indication 16297 16327	Adenocarcinoma of the Pancreas
T345	tradename 16351 16359	ABRAXANE
T347	tradename 16927 16936	 ABRAXANE
T349	activeingredient 16994 17004	paclitaxel
T351	tradename 17056 17067	ABRAXANE. 
T353	tradename 17104 17112	ABRAXANE
T355	activeingredient 17273 17283	paclitaxel
T357	tradename 17338 17346	ABRAXANE
T359	adversereaction 17482 17495	extravasation
T361	tradename 17630 17638	ABRAXANE
T363	adversereaction 17693 17719	infusion-related reactions
T365	adversereaction 17777 17803	hypersensitivity reactions
T367	tradename 17859 17871	ABRAXANE. 
T369	tradename 17960 17972	ABRAXANE. 
T371	tradename 18034 18042	ABRAXANE
T373	routeofadministration 18146 18157	Intravenous
T375	tradename 18175 18184	 ABRAXANE
T377	activeingredient 19207 19218	paclitaxel.
T379	tradename 19723 19731	ABRAXANE
T381	tradename 19979 19987	ABRAXANE
T383	tradename 20245 20253	ABRAXANE
T385	tradename 20528 20536	ABRAXANE
T387	tradename 21178 21186	ABRAXANE
T389	activeingredient 21539 21549	paclitaxel
T391	corecomposition 21564 21577	albumin-bound
T393	tradename 21650 21659	 ABRAXANE
T395	tradename 21816 21824	ABRAXANE
T397	tradename 21923 21924	 
T399	adversereaction 21924 21947	Bone marrow suppression
T401	adversereaction 21959 21971	neutropenia)
T403	tradename 22022 22034	ABRAXANE. 
T405	adversereaction 22055 22076	Grade 3-4 neutropenia
T407	indication 22110 22140	metastatic breast cancer (MBC)
T409	indication 22163 22197	non-small cell lung cancer (NSCLC)
T411	adversereaction 22256 22269	myelotoxicity
T413	indication 22363 22367	MBC)
T415	indication 22395 22400	NSCLC
T417	indication 22409 22427	pancreatic cancer)
T419	tradename 22449 22457	ABRAXANE
T421	tradename 22645 22653	ABRAXANE
T423	tradename 22682 22690	ABRAXANE
T425	indication 22737 22740	MBC
T427	indication 22744 22750	NSCLC.
T429	indication 22769 22772	MBC
T431	tradename 22819 22827	ABRAXANE
T433	indication 22953 22958	NSCLC
T435	tradename 23078 23086	ABRAXANE
T437	indication 23393 23423	adenocarcinoma of the pancreas
T439	tradename 23434 23442	ABRAXANE
T441	tradename 23817 23818	 
T443	adversereaction 23818 23836	Sensory neuropathy
T445	adversereaction 23929 23960	Grade 1 or 2 sensory neuropathy
T447	adversereaction 24021 24047	Grade 3 sensory neuropathy
T449	tradename 24067 24075	ABRAXANE
T451	indication 24123 24147	metastatic breast cancer
T453	indication 24192 24197	NSCLC
T455	tradename 24279 24287	ABRAXANE
T457	adversereaction 24333 24339	Sepsis
T459	tradename 24341 24342	 
T461	adversereaction 24342 24348	Sepsis
T463	adversereaction 24392 24403	neutropenia
T465	tradename 24417 24425	ABRAXANE
T467	co-administereddrug 24446 24458	gemcitabine.
T469	adversereaction 24665 24684	febrile neutropenia
T471	tradename 24696 24704	ABRAXANE
T473	co-administereddrug 24709 24720	gemcitabine
T475	adversereaction 24855 24866	Pneumonitis
T477	tradename 24868 24869	 
T479	adversereaction 24869 24880	Pneumonitis
T481	tradename 24957 24965	ABRAXANE
T483	co-administereddrug 24986 24998	gemcitabine.
T485	adversereaction 25043 25054	pneumonitis
T487	tradename 25069 25077	ABRAXANE
T489	co-administereddrug 25082 25093	gemcitabine
T491	adversereaction 25125 25137	pneumonitis.
T493	adversereaction 25208 25219	pneumonitis
T495	tradename 25260 25268	ABRAXANE
T497	co-administereddrug 25273 25285	gemcitabine.
T499	adversereaction 25292 25308	Hypersensitivity
T501	adversereaction 25338 25364	hypersensitivity reactions
T503	adversereaction 25376 25398	anaphylactic reactions
T505	adversereaction 25455 25480	hypersensitivity reaction
T507	tradename 25484 25492	ABRAXANE
T509	activeingredient 25601 25611	paclitaxel
T511	tradename 25672 25680	ABRAXANE
T513	tradename 25948 25956	ABRAXANE
T515	tradename 26060 26068	ABRAXANE
T517	indication 26105 26146	metastatic adenocarcinoma of the pancreas
T519	corecomposition 26458 26465	Albumin
T521	tradename 26475 26484	 ABRAXANE
T523	corecomposition 26494 26501	albumin
T525	corecomposition 26892 26900	albumin.
T527	tradename 26925 26934	 ABRAXANE
T529	activeingredient 27015 27025	paclitaxel
T531	corecomposition 27040 27053	albumin-bound
T533	tradename 27393 27405	ABRAXANE. 
T535	tradename 27670 27678	ABRAXANE
T537	tradename 27799 27807	ABRAXANE
T539	tradename 28208 28216	ABRAXANE
T541	indication 28220 28244	metastatic breast cancer
T543	adversereaction 28249 28257	alopecia
T545	adversereaction 28259 28270	neutropenia
T547	adversereaction 28272 28290	sensory neuropathy
T549	adversereaction 28292 28304	abnormal ECG
T551	adversereaction 28306 28322	fatigue/asthenia
T553	adversereaction 28324 28342	myalgia/arthralgia
T555	adversereaction 28344 28357	AST elevation
T557	adversereaction 28359 28389	alkaline phosphatase elevation
T559	adversereaction 28391 28397	anemia
T561	adversereaction 28399 28405	nausea
T563	adversereaction 28407 28417	infections
T565	adversereaction 28423 28431	diarrhea
T567	tradename 28516 28524	ABRAXANE
T569	co-administereddrug 28545 28556	carboplatin
T571	indication 28561 28587	non-small cell lung cancer
T573	adversereaction 28592 28598	anemia
T575	adversereaction 28600 28611	neutropenia
T577	adversereaction 28613 28629	thrombocytopenia
T579	adversereaction 28631 28639	alopecia
T581	adversereaction 28641 28662	peripheral neuropathy
T583	adversereaction 28664 28670	nausea
T585	adversereaction 28676 28683	fatigue
T587	tradename 28760 28768	ABRAXANE
T589	co-administereddrug 28789 28800	carboplatin
T591	indication 28805 28831	non-small cell lung cancer
T593	adversereaction 28836 28842	anemia
T595	adversereaction 28852 28861	pneumonia
T597	tradename 28946 28954	ABRAXANE
T599	adversereaction 28959 28970	neutropenia
T601	adversereaction 28977 28993	thrombocytopenia
T603	adversereaction 29004 29025	peripheral neuropathy
T605	tradename 29099 29107	ABRAXANE
T607	adversereaction 29112 29123	neutropenia
T609	adversereaction 29131 29147	thrombocytopenia
T611	adversereaction 29159 29165	anemia
T613	tradename 29243 29251	ABRAXANE
T615	adversereaction 29263 29274	neutropenia
T617	adversereaction 29282 29298	thrombocytopenia
T619	adversereaction 29310 29316	anemia
T621	tradename 29361 29369	ABRAXANE
T623	co-administereddrug 29390 29401	gemcitabine
T625	indication 29406 29431	pancreatic adenocarcinoma
T627	tradename 29562 29570	ABRAXANE
T629	adversereaction 29575 29586	neutropenia
T631	adversereaction 29588 29595	fatigue
T633	adversereaction 29597 29618	peripheral neuropathy
T635	adversereaction 29620 29626	nausea
T637	adversereaction 29628 29636	alopecia
T639	adversereaction 29638 29654	peripheral edema
T641	adversereaction 29656 29664	diarrhea
T643	adversereaction 29666 29673	pyrexia
T645	adversereaction 29675 29683	vomiting
T647	adversereaction 29685 29703	decreased appetite
T649	adversereaction 29705 29709	rash
T651	adversereaction 29715 29727	dehydration.
T653	tradename 29774 29782	ABRAXANE
T655	adversereaction 29825 29832	pyrexia
T657	adversereaction 29839 29850	dehydration
T659	adversereaction 29857 29866	pneumonia
T661	adversereaction 29876 29884	vomiting
T663	tradename 29968 29976	ABRAXANE
T665	adversereaction 29981 30002	peripheral neuropathy
T667	adversereaction 30009 30016	fatigue
T669	adversereaction 30026 30042	thrombocytopenia
T671	tradename 30115 30123	ABRAXANE
T673	adversereaction 30128 30139	neutropenia
T675	adversereaction 30150 30171	peripheral neuropathy
T677	tradename 30248 30256	ABRAXANE
T679	adversereaction 30268 30279	neutropenia
T681	adversereaction 30287 30303	thrombocytopenia
T683	adversereaction 30311 30318	fatigue
T685	adversereaction 30325 30346	peripheral neuropathy
T687	adversereaction 30354 30360	anemia
T689	adversereaction 30370 30378	diarrhea
T691	indication 30422 30446	Metastatic Breast Cancer
T693	tradename 30590 30598	ABRAXANE
T695	activeingredient 30602 30612	paclitaxel
T697	indication 30644 30669	metastatic breast cancer.
T699	tradename 30840 30850	ABRAXANE 
T701	activeingredient 30881 30891	Paclitaxel
T703	adversereaction 30945 30956	Neutropenia
T705	tradename 31016 31017	 
T707	adversereaction 31017 31033	Thrombocytopenia
T709	tradename 31093 31094	 
T711	adversereaction 31094 31100	Anemia
T713	tradename 31144 31145	 
T715	adversereaction 31145 31155	Infections
T717	adversereaction 31165 31184	Febrile Neutropenia
T719	adversereaction 31192 31210	Neutropenic Sepsis
T721	adversereaction 31224 31232	Bleeding
T723	indication 31324 31341	Metastatic Breast
T725	indication 31343 31349	Cancer
T727	tradename 31419 31429	ABRAXANE 
T729	dose 31429 31438	260 mg/m2
T731	activeingredient 31460 31470	Paclitaxel
T733	dose 31481 31490	175 mg/m2
T735	tradename 31510 31511	 
T737	adversereaction 31511 31538	Hypersensitivity Reaction c
T739	adversereaction 31627 31638	Bradycardia
T741	adversereaction 31657 31668	Hypotension
T743	tradename 31676 31677	 
T745	adversereaction 31677 31705	Severe Cardiovascular Events
T747	adversereaction 31712 31724	Abnormal ECG
T749	adversereaction 31797 31802	Cough
T751	adversereaction 31810 31817	Dyspnea
T753	adversereaction 31825 31843	Sensory Neuropathy
T755	adversereaction 31889 31896	Myalgia
T757	adversereaction 31899 31909	Arthralgia
T759	adversereaction 31954 31962	Asthenia
T761	adversereaction 32007 32028	Fluid Retention/Edema
T763	adversereaction 32093 32099	Nausea
T765	adversereaction 32161 32169	Vomiting
T767	adversereaction 32217 32225	Diarrhea
T769	adversereaction 32280 32289	Mucositis
T771	adversereaction 32342 32350	Alopecia
T773	adversereaction 32399 32419	Bilirubin Elevations
T775	adversereaction 32427 32458	Alkaline Phosphatase Elevations
T777	adversereaction 32499 32522	Injection Site Reaction
T779	activeingredient 32632 32642	Paclitaxel
T781	adversereaction 32734 32750	hypersensitivity
T783	adversereaction 32758 32766	flushing
T785	adversereaction 32768 32775	dyspnea
T787	adversereaction 32777 32787	chest pain
T789	adversereaction 32789 32801	hypotension)
T791	tradename 32960 32961	 
T793	adversereaction 32961 32972	Neutropenia
T795	indication 33030 33054	metastatic breast cancer
T797	dose 33182 33191	260 mg/m2
T799	activeingredient 33230 33240	paclitaxel
T801	dose 33264 33273	175 mg/m2
T803	adversereaction 33277 33289	Pancytopenia
T805	tradename 33438 33450	ABRAXANE. 
T807	tradename 33647 33655	ABRAXANE
T809	tradename 33782 33790	ABRAXANE
T811	activeingredient 33845 33855	paclitaxel
T813	corecomposition 33875 33882	albumin
T815	tradename 34258 34266	ABRAXANE
T817	tradename 35210 35221	ABRAXANE. 
T819	tradename 35351 35359	ABRAXANE
T821	tradename 35442 35450	ABRAXANE
T823	tradename 35619 35627	ABRAXANE
T825	tradename 36036 36044	ABRAXANE
T827	tradename 36350 36358	ABRAXANE
T829	tradename 36494 36502	ABRAXANE
T831	activeingredient 36536 36546	paclitaxel
T833	indication 37005 37031	Non-Small Cell Lung Cancer
T835	tradename 37071 37080	ABRAXANE/
T837	activeingredient 37117 37127	paclitaxel
T839	indication 37260 37294	non-small cell lung cancer (NSCLC)
T841	tradename 37345 37353	ABRAXANE
T843	routeofadministration 37377 37388	intravenous
T845	dose 37427 37436	100 mg/m2
T847	activeingredient 37482 37492	Paclitaxel
T849	routeofadministration 37526 37537	intravenous
T851	dose 37573 37582	200 mg/m2
T853	routeofadministration 37701 37714	intravenously
T855	tradename 37765 37774	ABRAXANE/
T857	activeingredient 37774 37784	paclitaxel
T859	activeingredient 37815 37825	paclitaxel
T861	tradename 38311 38319	ABRAXANE
T863	activeingredient 38331 38341	paclitaxel
T865	tradename 38565 38573	ABRAXANE
T867	tradename 38806 38814	ABRAXANE
T869	activeingredient 38852 38862	paclitaxel
T871	tradename 39088 39096	ABRAXANE
T873	dose 39098 39107	100 mg/m2
T875	frequency 39108 39115	weekly)
T877	activeingredient 39134 39144	Paclitaxel
T879	dose 39156 39165	200 mg/m2
T881	frequency 39166 39180	every 3 weeks)
T883	tradename 39368 39377	ABRAXANE/
T885	activeingredient 39430 39440	paclitaxel
T887	activeingredient 39505 39515	paclitaxel
T889	tradename 39761 39769	ABRAXANE
T891	activeingredient 39848 39858	paclitaxel
T893	tradename 40094 40102	ABRAXANE
T895	dose 40104 40113	100 mg/m2
T897	frequency 40114 40121	weekly)
T899	activeingredient 40145 40155	Paclitaxel
T901	dose 40167 40176	200 mg/m2
T903	frequency 40177 40191	every 3 weeks)
T905	tradename 40726 40734	ABRAXANE
T907	tradename 41007 41019	ABRAXANE.  
T909	indication 41053 41083	Adenocarcinoma of the Pancreas
T911	tradename 41146 41154	ABRAXANE
T913	indication 41255 41296	metastatic adenocarcinoma of the pancreas
T915	tradename 41440 41449	ABRAXANE/
T917	tradename 41603 41612	ABRAXANE/
T919	tradename 41704 41712	ABRAXANE
T921	tradename 41914 41922	ABRAXANE
T923	tradename 42123 42132	ABRAXANE/
T925	tradename 42149 42158	ABRAXANE(
T927	dose 42158 42168	125 mg/m2)
T929	tradename 42344 42353	ABRAXANE/
T931	tradename 42459 42468	ABRAXANE/
T933	tradename 42566 42575	ABRAXANE/
T935	tradename 42769 42777	ABRAXANE
T937	tradename 42994 43003	ABRAXANE/
T939	tradename 43056 43065	 ABRAXANE
T941	dose 43067 43077	125 mg/m2)
T943	tradename 44680 44689	ABRAXANE/
T945	tradename 44755 44763	ABRAXANE
T947	dose 44765 44775	125 mg/m2)
T949	indication 45348 45378	adenocarcinoma of the pancreas
T951	tradename 45392 45401	ABRAXANE/
T953	tradename 45708 45717	ABRAXANE/
T955	tradename 45918 45926	ABRAXANE
T957	tradename 45965 45973	ABRAXANE
T959	tradename 46085 46101	ABRAXANE-treated
T961	tradename 46159 46167	ABRAXANE
T963	tradename 46244 46253	ABRAXANE/
T965	tradename 46537 46546	ABRAXANE/
T967	tradename 46643 46651	ABRAXANE
T969	tradename 46716 46724	ABRAXANE
T971	activeingredient 46735 46745	Paclitaxel
T973	tradename 46896 46907	ABRAXANE. 
T975	activeingredient 47158 47168	paclitaxel
T977	tradename 47209 47221	ABRAXANE.  
T979	tradename 47327 47336	ABRAXANE.
T981	tradename 47349 47357	ABRAXANE
T983	activeingredient 47412 47422	paclitaxel
T985	corecomposition 47442 47449	albumin
T987	tradename 47605 47614	ABRAXANE.
T989	tradename 47868 47876	ABRAXANE
T991	activeingredient 48049 48059	paclitaxel
T993	tradename 48107 48118	ABRAXANE. 
T995	activeingredient 48364 48374	paclitaxel
T997	tradename 48456 48467	ABRAXANE. 
T999	tradename 48564 48572	ABRAXANE
T1001	activeingredient 48833 48843	paclitaxel
T1003	tradename 48885 48893	ABRAXANE
T1005	tradename 49050 49058	ABRAXANE
T1007	activeingredient 49211 49221	paclitaxel
T1009	tradename 49364 49376	ABRAXANE. 
T1011	tradename 49455 49463	ABRAXANE
T1013	activeingredient 49674 49684	paclitaxel
T1015	activeingredient 49763 49773	paclitaxel
T1017	activeingredient 49970 49980	paclitaxel
T1019	tradename 50197 50209	ABRAXANE. 
T1021	activeingredient 50566 50576	paclitaxel
T1023	tradename 50653 50661	ABRAXANE
T1025	activeingredient 50712 50722	paclitaxel
T1027	activeingredient 50928 50938	paclitaxel
T1029	tradename 51023 51031	ABRAXANE
T1031	tradename 51524 51536	ABRAXANE. 
T1033	tradename 51594 51602	ABRAXANE
T1035	tradename 51928 51939	ABRAXANE. 
T1037	activeingredient 51957 51967	paclitaxel
T1039	corecomposition 51982 51995	albumin-bound
T1041	dose 52070 52077	6 mg/m2
T1043	dose 52611 52618	3 mg/m2
T1045	activeingredient 52748 52758	paclitaxel
T1047	activeingredient 52787 52797	Paclitaxel
T1049	tradename 53184 53192	ABRAXANE
T1051	tradename 53316 53324	ABRAXANE
T1053	indication 53346 53370	metastatic breast cancer
T1055	tradename 53519 53530	ABRAXANE. 
T1057	tradename 53587 53595	ABRAXANE
T1059	indication 53644 53670	non-small cell lung cancer
T1061	tradename 54114 54122	ABRAXANE
T1063	tradename 54565 54573	ABRAXANE
T1065	activeingredient 54797 54807	paclitaxel
T1067	tradename 54914 54922	ABRAXANE
T1069	tradename 55013 55021	ABRAXANE
T1071	indication 55229 55270	metastatic adenocarcinoma of the pancreas
T1073	tradename 55422 55430	ABRAXANE
T1075	tradename 55827 55835	ABRAXANE
T1077	tradename 55999 56008	 ABRAXANE
T1079	nanoparticle 56036 56070	paclitaxel protein-bound particles
T1081	corecomposition 56099 56112	albumin-bound
T1083	nanoparticle 56117 56169	paclitaxel formulated as albumin-bound nanoparticles
T1085	particlediameter 56213 56228	130 nanometers.
T1087	activeingredient 56229 56239	Paclitaxel
T1089	tradename 56304 56312	ABRAXANE
T1091	inactiveingredient 56413 56428	Sodium Chloride
T1093	routeofadministration 56453 56464	intravenous
T1095	activeingredient 56516 56526	paclitaxel
T1097	corecomposition 56543 56551	albumin)
T1099	corecomposition 56586 56593	albumin
T1101	inactiveingredient 56606 56622	sodium caprylate
T1103	inactiveingredient 56627 56654	sodium acetyltryptophanate)
T1105	nanoparticle 56720 56769	paclitaxel formulated as albumin-bound particles.
T1107	tradename 56770 56778	ABRAXANE
T1109	tradename 56821 56829	ABRAXANE
T1111	activeingredient 56833 56843	paclitaxel
T1113	chemoclass 56847 56869	microtubule inhibitor.
T1115	activeingredient 56894 56904	paclitaxel
T1117	activeingredient 56908 56909	5
T1119	activeingredient 56912 56917	20- 1
T1121	activeingredient 56918 56919	2
T1123	activeingredient 56922 56923	4
T1125	activeingredient 56924 56925	7
T1127	activeingredient 56928 56930	10
T1129	activeingredient 56933 56966	13 -hexahydroxytax-11-en-9-one 4
T1131	activeingredient 56967 57008	10-diacetate 2-benzoate 13-ester with (2R
T1133	activeingredient 57009 57052	3S)-N-benzoyl-3-phenylisoserine. Paclitaxel
T1135	activeingredient 57092 57102	Paclitaxel
T1137	activeingredient 57173 57183	C47H51NO14
T1139	molecularweight 57210 57217	853.91.
T1141	tradename 57362 57371	 ABRAXANE
T1143	chemoclass 57377 57398	microtubule inhibitor
T1145	activeingredient 57701 57711	Paclitaxel
T1147	activeingredient 57910 57920	paclitaxel
T1149	tradename 57962 57970	ABRAXANE
T1151	dose 57989 58004	80 to 375 mg/m2
T1153	activeingredient 58080 58090	paclitaxel
T1155	tradename 58094 58105	ABRAXANE. 
T1157	routeofadministration 58115 58126	intravenous
T1159	tradename 58145 58153	ABRAXANE
T1161	activeingredient 58155 58165	paclitaxel
T1163	dose 58441 58456	80 to 300 mg/m2
T1165	activeingredient 58485 58495	paclitaxel
T1167	tradename 58500 58508	ABRAXANE
T1169	routeofadministration 58545 58556	intravenous
T1171	dose 58602 58611	260 mg/m2
T1173	tradename 58612 58620	ABRAXANE
T1175	dose 58700 58709	175 mg/m2
T1177	activeingredient 58710 58720	paclitaxel
T1179	tradename 58835 58843	ABRAXANE
T1181	activeingredient 58853 58863	paclitaxel
T1183	tradename 58949 58957	ABRAXANE
T1185	activeingredient 59004 59014	paclitaxel
T1187	activeingredient 59174 59184	paclitaxel
T1189	tradename 59225 59233	ABRAXANE
T1191	activeingredient 59265 59275	paclitaxel
T1193	activeingredient 59346 59356	paclitaxel
T1195	tradename 59362 59370	ABRAXANE
T1197	activeingredient 59399 59409	paclitaxel
T1199	activeingredient 59510 59520	paclitaxel
T1201	activeingredient 59688 59699	paclitaxel.
T1203	volumeofdistribution 59751 59757	1741 L
T1205	activeingredient 59864 59875	paclitaxel.
T1207	activeingredient 59963 59973	paclitaxel
T1209	activeingredient 60150 60160	paclitaxel
T1211	activeingredient 60636 60646	paclitaxel
T1213	dose 60859 60874	80 to 300 mg/m2
T1215	activeingredient 60904 60914	paclitaxel
T1217	clearance 60927 60942	13 to 30 L/h/m2
T1219	plasmahalflife 60988 61003	13 to 27 hours.
T1221	dose 61035 61044	260 mg/m2
T1223	tradename 61054 61062	ABRAXANE
T1225	activeingredient 61515 61525	paclitaxel
T1227	tradename 61536 61544	ABRAXANE
T1229	activeingredient 61791 61802	paclitaxel.
T1231	activeingredient 62039 62049	paclitaxel
T1233	activeingredient 62089 62099	paclitaxel
T1235	activeingredient 62304 62314	paclitaxel
T1237	tradename 62617 62625	ABRAXANE
T1239	indication 62743 62784	metastatic adenocarcinoma of the pancreas
T1241	activeingredient 63105 63115	paclitaxel
T1243	tradename 63126 63134	ABRAXANE
T1245	activeingredient 63344 63354	paclitaxel
T1247	tradename 63464 63472	ABRAXANE
T1249	activeingredient 63738 63749	paclitaxel.
T1251	tradename 63789 63797	ABRAXANE
T1253	tradename 63884 63892	ABRAXANE
T1255	indication 63919 63924	NSCLC
T1257	activeingredient 63972 63982	paclitaxel
T1259	activeingredient 64199 64210	paclitaxel.
T1261	tradename 64250 64258	ABRAXANE
T1263	tradename 64312 64320	ABRAXANE
T1265	tradename 64490 64498	ABRAXANE
T1267	activeingredient 64522 64532	Paclitaxel
T1269	tradename 64645 64653	ABRAXANE
T1271	activeingredient 64746 64756	paclitaxel
T1273	corecomposition 64771 64784	albumin-bound
T1275	dose 65215 65229	3 and 12 mg/m2
T1277	frequency 65229 65234	/week
T1279	activeingredient 65443 65453	paclitaxel
T1281	corecomposition 65468 65481	albumin-bound
T1283	dose 65551 65559	54 mg/m2
T1285	dose 65575 65584	175 mg/m2
T1287	indication 65623 65647	Metastatic Breast Cancer
T1289	tradename 65818 65826	ABRAXANE
T1291	indication 65830 65855	metastatic breast cancer.
T1293	tradename 65904 65912	ABRAXANE
T1295	dose 65967 65976	175 mg/m2
T1297	indication 65997 66022	metastatic breast cancer.
T1299	dose 66060 66069	300 mg/m2
T1301	indication 66114 66139	metastatic breast cancer.
T1303	indication 66332 66357	metastatic breast cancer.
T1305	tradename 66396 66404	ABRAXANE
T1307	dose 66418 66427	260 mg/m2
T1309	activeingredient 66462 66472	paclitaxel
T1311	dose 66486 66495	175 mg/m2
T1313	tradename 67101 67109	ABRAXANE
T1315	activeingredient 67330 67340	paclitaxel
T1317	indication 67525 67549	Metastatic Breast Cancer
T1319	tradename 67557 67566	 ABRAXANE
T1321	dose 67567 67576	260 mg/m2
T1323	activeingredient 67578 67588	Paclitaxel
T1325	dose 67599 67608	175 mg/m2
T1327	indication 68583 68609	Non-Small Cell Lung Cancer
T1329	indication 68718 68744	non-small cell lung cancer
T1331	tradename 68756 68764	ABRAXANE
T1333	activeingredient 68800 68810	paclitaxel
T1335	indication 68903 68930	non-small cell lung cancer.
T1337	tradename 68933 68941	ABRAXANE
T1339	routeofadministration 68965 68976	intravenous
T1341	dose 69015 69024	100 mg/m2
T1343	activeingredient 69070 69080	Paclitaxel
T1345	routeofadministration 69114 69125	intravenous
T1347	dose 69161 69170	200 mg/m2
T1349	routeofadministration 69289 69302	intravenously
T1351	tradename 69353 69362	ABRAXANE/
T1353	activeingredient 69362 69372	paclitaxel
T1355	tradename 69963 69972	ABRAXANE/
T1357	activeingredient 70079 70089	paclitaxel
T1359	indication 70293 70319	Non-Small Cell Lung Cancer
T1361	tradename 70356 70365	 ABRAXANE
T1363	dose 70367 70376	100 mg/m2
T1365	frequency 70377 70384	weekly)
T1367	activeingredient 70408 70418	Paclitaxel
T1369	dose 70430 70439	200 mg/m2
T1371	frequency 70440 70454	every 3 weeks)
T1373	indication 70970 71000	Adenocarcinoma of the Pancreas
T1375	tradename 71102 71110	ABRAXANE
T1377	indication 71186 71228	metastatic adenocarcinoma of the pancreas.
T1379	tradename 71868 71877	ABRAXANE/
T1381	tradename 72160 72169	ABRAXANE/
T1383	tradename 72190 72198	ABRAXANE
T1385	dose 72199 72208	125 mg/m2
T1387	routeofadministration 72215 72226	intravenous
T1389	dose 72279 72289	1000 mg/m2
T1391	routeofadministration 72296 72307	intravenous
T1393	dose 72425 72435	1000 mg/m2
T1395	routeofadministration 72442 72453	intravenous
T1397	dose 72553 72563	1000 mg/m2
T1399	indication 73601 73631	Adenocarcinoma of the Pancreas
T1401	tradename 73650 73660	 ABRAXANE(
T1403	dose 73660 73670	125 mg/m2)
T1405	tradename 74288 74296	ABRAXANE
T1407	activeingredient 75997 76007	paclitaxel
T1409	tradename 76635 76643	ABRAXANE
T1411	tradename 76835 76843	ABRAXANE
T1413	tradename 76971 76979	ABRAXANE
T1415	tradename 77451 77459	ABRAXANE
T1417	tradename 77708 77716	ABRAXANE
T1419	company 78079 78098	Celgene Corporation
T1421	tradename 78118 78126	ABRAXANE
T1423	company 78157 78175	Abraxis BioScience
T1425	company 78177 78181	LLC.
T1427	company 78194 78212	Abraxis BioScience
T1429	company 78214 78218	LLC.
T1431	company 78242 78260	Abraxis BioScience
T1433	company 78262 78265	LLC
T1435	company 78298 78318	Celgene Corporation.
T1437	tradename 78437 78447	 ABRAXANE
T1439	activeingredient 78466 78476	paclitaxel
T1441	corecomposition 78530 78543	albumin-bound
T1443	tradename 78603 78611	ABRAXANE
T1445	tradename 78764 78783	ABRAXANE? ABRAXANE
T1447	indication 78938 78964	non-small cell lung cancer
T1449	tradename 79206 79214	ABRAXANE
T1451	tradename 79273 79284	ABRAXANE? 
T1453	tradename 79299 79307	ABRAXANE
T1455	tradename 79413 79425	ABRAXANE.  
T1457	tradename 79471 79480	ABRAXANE?
T1459	tradename 79500 79508	ABRAXANE
T1461	tradename 79698 79716	ABRAXANE. ABRAXANE
T1463	tradename 79851 79859	ABRAXANE
T1465	tradename 79934 79945	ABRAXANE. 
T1467	tradename 80104 80115	ABRAXANE. 
T1469	tradename 80175 80183	ABRAXANE
T1471	tradename 80268 80276	ABRAXANE
T1473	tradename 80588 80599	ABRAXANE? 
T1475	tradename 80626 80634	ABRAXANE
T1477	tradename 80752 80761	ABRAXANE.
T1479	tradename 80830 80841	ABRAXANE. 
T1481	tradename 80878 80886	ABRAXANE
T1483	tradename 80914 80922	ABRAXANE
T1485	routeofadministration 80947 80958	intravenous
T1487	tradename 81045 81056	ABRAXANE. 
T1489	tradename 81094 81114	ABRAXANE? ABRAXANE
T1491	tradename 81188 81196	ABRAXANE
T1493	tradename 81458 81466	ABRAXANE
T1495	tradename 81628 81636	ABRAXANE
T1497	tradename 81879 81887	ABRAXANE
T1499	tradename 82132 82140	ABRAXANE
T1501	tradename 82211 82219	ABRAXANE
T1503	tradename 82870 82881	ABRAXANE. 
T1505	tradename 83103 83114	ABRAXANE. 
T1507	tradename 83297 83308	ABRAXANE. 
T1509	tradename 83425 83433	ABRAXANE
T1511	tradename 83549 83560	ABRAXANE? 
T1513	activeingredient 83579 83589	paclitaxel
T1515	corecomposition 83606 83614	albumin)
T1517	corecomposition 83641 83648	albumin
T1519	inactiveingredient 83661 83677	sodium caprylate
T1521	inactiveingredient 83682 83709	sodium acetyltryptophanate)
T1523	company 83843 83862	Celgene Corporation
T1525	tradename 83881 83889	ABRAXANE
T1527	company 83920 83938	Abraxis BioScience
T1529	company 83940 83944	LLC.
T1531	company 83957 83975	Abraxis BioScience
T1533	company 83977 83981	LLC.
T1535	company 84005 84023	Abraxis BioScience
T1537	company 84025 84028	LLC
T1539	company 84061 84081	Celgene Corporation.
